Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Currently delivers to more than 18,000 pin codes across India
Dr Reddy’s Laboratories Ltd., a global pharmaceutical company announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by its wholly-owned subsidiary, Svaas Wellness Limited. ‘Celevida Wellness’ aims to become a one-stop solution for personalised diabetic care for Type 2 diabetic and pre-diabetic individuals.
The website will host the Celevida range of products as well as other third-party brands to offer a product portfolio that takes care of a diabetic patient’s daily nutritional requirement and at the same time fits into the complete occasion framework of the day i.e., breakfast, lunch, dinner, snacks, beverages, meal replacement, etc. Products are on-boarded onto the platform after a stringent product selection process that involves rigorous diligence study of their nutritional composition. The website currently delivers to more than 18,000 pin codes across India.
M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), said, “We see ‘Celevida Wellness’ as becoming a comprehensive one-stop solution for Type 2 diabetic and pre-diabetic patients offering meals, personalised dietary and health information, and in due course, features such as a digital diary to track health patterns, and on-call nutritionists. As a business, this launch strengthens our presence in the nutraceutical segment and also marks our foray into the D2C space in keeping with evolving pharma business models as we aim to reach more than 1.5 billion patients by the year 2030.